Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIBERTY GLUCOSE CONTROL, MODEL 2120031

K-Number: K052980 · 2005-11-30

ApplicantLiberty Healthcare Group, Inc.
Decision Date2005-11-30
Product CodeJJX
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

LIBERTY GLUCOSE CONTROL, MODEL 2120031 is the device name listed in this FDA 510(k) record. The listed applicant is Liberty Healthcare Group, Inc.. It received FDA 510(k) clearance on 2005-11-30 under 510(k) number K052980. The device is classified under product code JJX. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIBERTY GLUCOSE CONTROL, MODEL 2120031?

LIBERTY GLUCOSE CONTROL, MODEL 2120031 is a medical device that received FDA 510(k) clearance on 2005-11-30. The listed applicant is Liberty Healthcare Group, Inc.. The 510(k) number is K052980.

When did LIBERTY GLUCOSE CONTROL, MODEL 2120031 receive FDA 510(k) clearance?

LIBERTY GLUCOSE CONTROL, MODEL 2120031 received FDA 510(k) clearance on 2005-11-30, under 510(k) number K052980.

Who is the listed applicant for LIBERTY GLUCOSE CONTROL, MODEL 2120031?

The FDA 510(k) record lists Liberty Healthcare Group, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LIBERTY GLUCOSE CONTROL, MODEL 2120031?

The FDA product code for LIBERTY GLUCOSE CONTROL, MODEL 2120031 is JJX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Liberty Healthcare Group, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K063855LIBERTY NORMAL GLUCOSE CONTROL SOLUTION, MODEL 2120045/ HIGH GLUCOSE CONTROL SOLUTION, MODEL 2120047K060706LIBERTY NORMAL GLUCOSE CONTROL SOLUTIONK060481LIBERTY GLUCOSE CONTROL SOLUTIONK060426LIBERTY GLUCOSE NORMAL CONTROL SOLUTIONS, MODEL 2120041

Related Devices (Code: JJX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K170678Beta-CrossLaps CalCheck 5Roche DiagnosticsK162173Elecsys CYFRA 21-1 CalCheck 5Roche DiagnosticsK162514Multichem A1cTechnopath ManufacturingK161874Audit MicroControls Linearity DROP LQ Blood GlucoseAalto Scientific, Ltd.K161526LIAISON CMV IgM Serum Control SetDiaSorin, Inc.K161522LIAISON EBV IgM Serum Control SetDiaSorin, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑